| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $30K | +296.7% | -85.6% |
| SG&A Expense | $307K | -25.5% | -45.7% |
| Operating Income | -$387K | +17.7% | +52.2% |
| Pre-tax Income | -$579K | +60.1% | +51.7% |
| Net Income | -$579K | +60.1% | +51.7% |
| EPS (Basic) | -$0.36 | +60.0% | +61.7% |
| EPS (Diluted) | -$0.36 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $86K | — | -48.1% |
| Current Assets | $86K | +4764.8% | -68.2% |
| Total Assets | $136K | +161.9% | -68.3% |
| Current Liabilities | $4.0M | -27.3% | -6.7% |
| Long-term Debt | $3.5M | +42.6% | +77.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$646K | — | — |
| Financing Cash Flow | $720K | — | — |
| +60.0% |
| +61.7% |
| $6.1M |
| +10.3% |
| +39.1% |
| Stockholders' Equity | -$5.9M | -8.8% | -50.8% |